Experts halt study to announce breast cancer breakthrough

Researchers were so excited by early results from a study on preventing the recurrence of breast cancer they halted their work so more women could benefit from the findings.

The study, published online by the New England Journal of Medicine, showed breast cancer patients who followed up five years of tamoxifen treatment with letrozole, an oestrogen suppresser, cut the risk of recurrence by nearly half.